Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 253-425-0 | CAS number: 37247-91-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Reasonably well-documented publication. In this study, intestinal absorption of magnesium was studied when administered to rats using magnesium oxide as test material. Since magnesium is present in dolomitic lime as the oxide, the current study is in principle relevant for evaluating oral absorption. However, prior to administration MgO was dissolved in HCl, enhancing solubility, thus possibly also bioavailability. The study may therefore not be fully appropriate for assessing oral absorption of magnesium from dolomitic lime substances when swallowing of the solid substance is considered.
Data source
Reference
- Reference Type:
- publication
- Title:
- Study of magnesium bioavailability using stable isotopes and the inductively-coupled plasma mass spectrometry technique in the rat: single and double labelling approaches
- Author:
- Coudray, C.; et al.
- Year:
- 1 997
- Bibliographic source:
- Br. J. Nutr. 77, 957-970
Materials and methods
- Objective of study:
- absorption
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Toxicokinetics, oral absorption (rat)
- GLP compliance:
- no
Test material
- Reference substance name:
- Magnesium oxide
- EC Number:
- 215-171-9
- EC Name:
- Magnesium oxide
- Cas Number:
- 1309-48-4
- Molecular formula:
- MgO
- IUPAC Name:
- 1309-48-4
- Details on test material:
- - Name of test material (as cited in study report): magnesium oxide
No further details are given.
Constituent 1
- Radiolabelling:
- yes
- Remarks:
- enriched Mg isotopes (25Mg and 26Mg)
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Animals were derived from the colony of laboratory animals of the Institut National de la Recherche Agronomique, France.
- Age at study initiation: 7 weeks
- Weight at study initiation: 180 g
- Diet: ad libitum (during acclimation period); semi-purified diet containing 1070 mg Mg/kg and distilled water
- Water: ad libitum (during acclimation period)
- Acclimation period: 16 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-22
- Humidity (%): 45-50
- Photoperiod: 12 hours dark/light cycle
No further details are given.
Administration / exposure
- Route of administration:
- oral: unspecified
- Vehicle:
- water
- Details on exposure:
- Single labelling method: Stable isotope administration: The isotopic analysis of 25Mg as MgO yielded the following atom percent figures:
24Mg: 0.95 %,
25Mg: 98.82 %,
26Mg: 0.23 %.
25Mg (100 mg) as oxide was moistened with distilled water and then HCl was added to transform the oxide into soluble chloride of Mg. The solution was diluted with water and the pH adjusted at 6 with powdered NaHCO3.
Double labelling method: table isotope administration: The isotopic analysis of 26Mg as MgO yielded the following atom percent figures:
24Mg: 0.41 %
25Mg: 0.18 %
26Mg: 99.41 %.
26Mg (100 mg) as MgO was dissolved as indicated for 25Mg isotope. 1.5 ml diluted 26Mg isotope solution (1 mg/mL) was mixed with 5 g diet without Mg. - Duration and frequency of treatment / exposure:
- Single labelling method: 1 administration
Double labelling method: 2 hours
Doses / concentrations
- Remarks:
- Doses / Concentrations:
Single labelling method: On day 0 the animals in group 1 received 6 mg 25Mg and the animals in group 2 received 12 mg 25Mg by oral administration.
Double labelling method: On day 0 the animals received their diet containing 26Mg isotope (exact amount of 26Mg ingested was determined for each animal). Thereafter animals received 0.25 ml 25Mg (1.15 mg/ml) intravenously.
- No. of animals per sex per dose / concentration:
- Single labelling method: 10 rats were divided into two groups of 5 animals each.
- Control animals:
- not specified
- Positive control reference chemical:
- no data
- Details on study design:
- Single labelling method: Two successive 6 days balance periods were performed, one before and another after the administration of stable isotope. Daily Mg intake was determined and the faeces and urine of each rat were quantitatively collected.
- Details on dosing and sampling:
- Single labelling method: The faeces and urine of each rat for each day (before and for 6 days after isotope administration) were collected quantitatively. Animals were lightly anaesthetised and blood was sampled from the retro bulbar sinus before and at 0, 4, 8, 12 hours and 1, 3, and 6 days after stable isotope administration.
Double labelling method: Faeces and urine of each rat were collected before isotope administration (baseline) and then 12 hours collections were made quantitatively during the first 2 days and daily for the next 3 days after isotope administration. Animals were lightly anaesthetised and blood was sampled from the retro bulbar sinus before and at day 2 after stable-isotope administration.
Analysis: Urine volume was determined. Mg concentration and isotope ratios in plasma and urine were determined by ICP/MS. The Mg concentration and isotope ratios in faeces were determined by ICP/MS. Total Mg was determined by flame atomic absorption spectrometry. - Statistics:
- Throughout the present study, results are expressed as mean and standard error (SE). The statistical significance of differences (P<0.05) was assessed using Student's t-test.
Results and discussion
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- True absorption of Mg in rats based on faecal elimination and total non-absorbed dose, and are reported as 63-67 % and 54-69 % for doses of 33 and 66 mg/kg bw, respectively.
True absorption based on blood and urine data was calculated as 36-39 %. - Details on distribution in tissues:
- No data (not investigated).
Metabolite characterisation studies
- Metabolites identified:
- no
- Details on metabolites:
- Not relevant for magnesium.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): other: Bioaccumulation is not relevant for magnesium.
True absorption of magnesium based on blood and urine data determined at 36-39 %.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.